Nurse Practitioner, Family · London, KY
NPI
1710281399
Since 2010
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
192 London Shopping Ctr, Ste 2
London, KY, 40741
Phone (606) 330-7370
Groups this clinician bills Medicare through
Medicare paid, 2024
$29K
820 services
Medicare patients, 2024
342
Average age 72
Drug cost, 2024
$1.4M
3,615 prescriptions
Company payments, 2025
$1,742
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rachel Davenport-Campbell was code 99214 (office e&m - established), 251 times for 227 patients. In total Rachel Davenport-Campbell billed 820 services in 14 codes, and Medicare paid $29K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-12-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 251 | 227 | $77.46 | $19K |
| 99213 Office E&M - Established | Office | 83 | 79 | $50.72 | $4,210 |
| 94618 Pulmonary Function Testing | Office | 56 | 56 | $21.17 | $1,185 |
| 99212 Office E&M - Established | Office | 49 | 48 | $33.66 | $1,649 |
| G0008 Administration of influenza virus vaccine | Office | 19 | 18 | $29.46 | $560 |
| 90662 Vaccine Product | Office | 14 | 13 | $80.41 | $1,126 |
By year: 2022 $32K for 613 services; 2023 $24K for 459 services; 2024 $29K for 820 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rachel Davenport-Campbell prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 614 prescriptions and refills. In total Rachel Davenport-Campbell wrote 3,615 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 614 | 691 | 232 | $16K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 347 | 554 | 115 | $350K |
| Montelukast Sodium Generic | 344 | 856 | 123 | $2,277 |
| Fluticasone Propionate Generic | 245 | 427 | 114 | $1,968 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 179 | 266 | 56 | $125K |
| Azelastine Hcl Generic | 162 | 276 | 94 | $2,911 |
| Ventolin Hfa Albuterol Sulfate | 150 | 169 | 60 | $10K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 144 | 229 | 55 | $142K |
| Levocetirizine Dihydrochloride Generic | 129 | 275 | 47 | $968 |
| Breo Ellipta Fluticasone/Vilanterol | 124 | 178 | 37 | $68K |
| Spiriva Respimat Tiotropium Bromide | 120 | 240 | 48 | $122K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 104 | 136 | 30 | $62K |
| Temazepam Generic | 89 | 89 | 21 | $1,146 |
| Roflumilast Generic | 87 | 115 | 23 | $8,068 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 71 | 127 | 24 | $11K |
Brand drugs: 2,049 claims; generic drugs: 1,566 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rachel Davenport-Campbell $1,742 ($1,742 in general payments such as food, travel and fees) from 18 companies. The largest payer was GlaxoSmithKline, LLC. with $446.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 26 | $446 |
| AstraZeneca Pharmaceuticals LP AZN | 11 | $218 |
| Harmony Biosciences LLC HRMY | 8 | $198 |
| Amgen Inc. AMGN | 5 | $128 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $112 |
| Genzyme Corporation SNY | 5 | $109 |
| Electromed, Inc. ELMD | 7 | $88.1 |
| Verona Pharma, Inc. VRNA | 4 | $88.03 |
| Grifols USA, LLC | 4 | $78.84 |
| Insmed, Inc. INSM | 3 | $72.66 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.